Announcement
12 Mar 2021
On 12 March 2021, Biomedical Advanced Research and Development Authority (BARDA) announced awarding USD 62.7 million to Moderna in support of the additional development of the COVID-19 vaccine.
Source
Sign in to access
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
12 Mar 2021
Revocation date:
No revocation date
Updated: 12 Mar 2021
State aid, unspecified
In force
On 12 March 2021, Biomedical Advanced Research and Development Authority (BARDA) announced collaborating with Moderna Inc to further the development of “mRNA-1273 vaccine candidate including a Phas...
Sign in to see more
Related State Acts
15 Jun 2021
United States of America: Moderna is awarded $144.1 million in support of the COVID-19 vaccine development for pediatric population, aged between six months to 12 years old
18 Apr 2021
United States of America: Moderna is awarded $236.4 million in support of the additional development of mRNA-1273 vaccine
12 Mar 2021
United States of America: Moderna is awarded $62.7 million in support of the COVID-19 vaccine additional development
11 Feb 2021
United States of America: U.S. Government purchases addition COVID-19 vaccine doses from Moderna for $1.750 billion
11 Dec 2020
United States of America: Moderna is awarded a $1.66 billion contract for the manufacture and delivery of additional COVID-19 vaccines doses
25 Jul 2020
United States of America: Moderna is awarded $472 million in support of the Phase 3 clinical trial of a COVID-19 vaccine
24 May 2020
United States of America: Moderna is awarded $53 million in support of the COVID-19 vaccine manufacturing capacity expansion
16 Apr 2020
United States of America: Moderna is awarded $430 million for the COVID-19 vaccine development process
Threads
See all
This state act is not part of any Thread yet.